Looking through the door of meth labs

meth labs

Looking through the door of meth labs: Methamphetamine ‘cooks’ in domestic labs are most likely to be male, Caucasian and about 30 years’ old, according to University of Queensland researchers. Their study included 125 cooks from 24 countries, providing some insight into the illicit activity characterised in the popular television series Breaking Bad. Dr Cheneal Puljević from […]

Read More… from Looking through the door of meth labs

Clearer picture on HRT & breast cancer

bra

A new study, led by experts at the Universities of Nottingham and Oxford, provides a clearer and more detailed picture on which women are at increased risk of breast cancer when using different HRT treatments. The results of the study, published in The BMJ, confirm that HRT use is associated with increased risks of breast […]

Read More… from Clearer picture on HRT & breast cancer

Imagine you are an Aluminum Atom

book

Imagine You Are An Aluminum Atom: Discussions With Mr. Aluminum: I have written a book on aluminium. It is my first book and it will almost certainly be my last. Pre-publication, the most common question I receive about the book is why I wrote it. I think it began as a reference guide to living in […]

Read More… from Imagine you are an Aluminum Atom

Calls for medicinal cannabis for severe epilepsy

cannabis for severe epilepsy

Families of children with severe epilepsy and charities are pleading with the UK government to act on its promises for easier access to cannabis-based medicines. The call comes two years after the government legalised access to them following the high-profile campaigns by the families of Alfie Dingley and Billy Caldwell, two boys with intractable epilepsy, […]

Read More… from Calls for medicinal cannabis for severe epilepsy

WHO: Solidarity Therapeutics Trial

Solidarity Therapeutics Trial

Solidarity Therapeutics Trial produces conclusive evidence on the effectiveness of repurposed drugs for COVID-19 in record time In just six months, the world’s largest randomized control trial on COVID-19 therapeutics has generated conclusive evidence on the effectiveness of repurposed drugs for the treatment of COVID-19. Interim results from the Solidarity Therapeutics Trial, coordinated by the […]

Read More… from WHO: Solidarity Therapeutics Trial

Drugs bill warning over US/UK trade deal

Unused prescription drugs

The NHS would spend billions of pounds more on drugs if it had to pay US prices following a US/UK trade deal. According to a new study by researchers at Brigham and Women’s Hospital in Boston, Harvard Medical School, and the University of Oxford, published by the Journal of the Royal Society of Medicine, NHS England […]

Read More… from Drugs bill warning over US/UK trade deal

Gout medicine halts progression of coronary disease

gout medicine

Common medicine used to treat gout found to prevent progression of coronary disease – international study published in New England Journal of Medicine by Perth researchers. A major clinical trial involving 5,500 patients in Australia and the Netherlands found heart attacks and the need for coronary stenting or bypass surgery reduced by 30% in patients […]

Read More… from Gout medicine halts progression of coronary disease

Steroid found to improve survival of critically ill COVID-19 patients

steroid

A new international study published today has shown that treating critically ill patients with COVID-19 with the steroid hydrocortisone improves their chances of recovery. The study, led in the UK by Professor Anthony Gordon from Imperial College London with collaborators from the Intensive Care National Audit & Research Centre, found that patients receiving intensive care […]

Read More… from Steroid found to improve survival of critically ill COVID-19 patients

Guidance on Brexit transition period

transition period

ABPI response to MHRA guidance for the end of the transition period The MHRA has published information for pharmaceutical companies preparing for the end of the Brexit transition period.​ The guidance provides some information on how to operate from 1 January 2021, including on licensing of medicines and devices, clinical trials, exporting active substances for […]

Read More… from Guidance on Brexit transition period